Trial
NCT05008926
The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients
Phase IIISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University Hospital, Brest
Collaborators
—
Condition
Brain Injuries
Intervention
Naloxegol
Why stopped
interim analysis - Results ongoing
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16